These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8548314)

  • 1. Brain dopamine transporter: gender differences and effect of chronic haloperidol.
    Rivest R; Falardeau P; Di Paolo T
    Brain Res; 1995 Sep; 692(1-2):269-72. PubMed ID: 8548314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
    Cyr M; Morissette M; Barden N; Beaulieu S; Rochford J; Di Paolo T
    Neuroscience; 2001; 102(1):151-8. PubMed ID: 11226678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of dopamine transport in the striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(p-isothiocyanatophenethyl) spiperone (NIPS) treatment.
    Thompson TL; Bridges SR; Weirs WJ
    Brain Res Bull; 2001 Apr; 54(6):631-8. PubMed ID: 11403989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat.
    Régo JC; Syringas M; Leblond B; Costentin J; Bonnet JJ
    Br J Pharmacol; 1999 Sep; 128(1):51-60. PubMed ID: 10498834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.
    Claye LH; Akunne HC; Davis MD; DeMattos S; Soliman KF
    Mol Neurobiol; 1995; 11(1-3):55-66. PubMed ID: 8561968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
    J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single (-)-nicotine injection causes change with a time delay in the affinity of striatal D2 receptors for antagonist, but not for agonist, nor in the D2 receptor mRNA levels in the rat substantia nigra.
    Li XM; Zoli M; Finnman UB; Le Novère N; Changeux JP; Fuxe K
    Brain Res; 1995 May; 679(1):157-67. PubMed ID: 7648259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat.
    Rajakumar N; Laurier L; Niznik HB; Stoessl AJ
    Synapse; 1997 Jul; 26(3):199-208. PubMed ID: 9183809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites.
    Refahi-Lyamani F; Saadouni S; Costentin J; Bonnet JJ
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):136-45. PubMed ID: 7770096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
    Pehek EA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats.
    Lau YS; Petroske E; Meredith GE; Wang JQ
    Neuropharmacology; 2003 Dec; 45(7):986-94. PubMed ID: 14573391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a tropane radioligand, [(3)H]2beta-propanoyl-3beta-(4-tolyl) tropane ([(3)H]PTT), for dopamine transport sites in rat brain.
    Letchworth SR; Smith HR; Porrino LJ; Bennett BA; Davies HM; Sexton T; Childers SR
    J Pharmacol Exp Ther; 2000 May; 293(2):686-96. PubMed ID: 10773045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides.
    Silvia CP; Jaber M; King GR; Ellinwood EH; Caron MG
    Neuroscience; 1997 Feb; 76(3):737-47. PubMed ID: 9135047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.
    Inoue A; Miki S; Seto M; Kikuchi T; Morita S; Ueda H; Misu Y; Nakata Y
    Eur J Pharmacol; 1997 Feb; 321(1):105-11. PubMed ID: 9083792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute L-DOPA pretreatment potentiates 6-hydroxydopamine-induced toxic effects on nigro-striatal dopamine neurons in mice.
    Naudin B; Bonnet JJ; Costentin J
    Brain Res; 1995 Dec; 701(1-2):151-7. PubMed ID: 8925278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration.
    Letchworth SR; Sexton T; Childers SR; Vrana KE; Vaughan RA; Davies HM; Porrino LJ
    J Neurochem; 1999 Nov; 73(5):1982-9. PubMed ID: 10537056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo characterization of newly developed iodinated 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazine derivatives in rats: limited value as dopamine transporter SPECT ligands.
    Rijks LJ; Booij J; Doornbos T; Boer GJ; Ronken E; de Bruin K; Vermeulen RJ; Janssen AG; Van Royen EA
    Synapse; 1996 Jul; 23(3):201-7. PubMed ID: 8807748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and preliminary characterization of a high-affinity novel radioligand for the dopamine transporter.
    Dutta AK; Reith ME; Madras BK
    Synapse; 2001 Feb; 39(2):175-81. PubMed ID: 11180505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.